ACTR1A

gene
On this page

Also known as ARP1Arp1A

Summary

ACTR1A (actin related protein 1A, HGNC:167) is a protein-coding gene on chromosome 10q24.32, encoding Alpha-centractin (P61163). Part of the ACTR1A/ACTB filament around which the dynactin complex is built. It is a selective cancer dependency (DepMap: 78.1% of cell lines).

This gene encodes a 42.6 kD subunit of dynactin, a macromolecular complex consisting of 10-11 subunits ranging in size from 22 to 150 kD. Dynactin binds to both microtubules and cytoplasmic dynein. It is involved in a diverse array of cellular functions, including ER-to-Golgi transport, the centripetal movement of lysosomes and endosomes, spindle formation, chromosome movement, nuclear positioning, and axonogenesis. This subunit is present in 8-13 copies per dynactin molecule, and is the most abundant molecule in the dynactin complex. It is an actin-related protein, and is approximately 60% identical at the amino acid level to conventional actin.

Source: NCBI Gene 10121 — RefSeq curated summary.

At a glance

  • GWAS associations: 13
  • Clinical variants (ClinVar): 39 total — 2 pathogenic
  • Cancer dependency (DepMap): dependent in 78.1% of screened cell lines
  • MANE Select transcript: NM_005736

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:167
Approved symbolACTR1A
Nameactin related protein 1A
Location10q24.32
Locus typegene with protein product
StatusApproved
AliasesARP1, Arp1A
Ensembl geneENSG00000138107
Ensembl biotypeprotein_coding
OMIM605143
Entrez10121

Gene structure

Transcript identifiers

Ensembl transcripts: 19 — 14 protein_coding, 4 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay

ENST00000369905, ENST00000470322, ENST00000480947, ENST00000481044, ENST00000487599, ENST00000494549, ENST00000636707, ENST00000900299, ENST00000900300, ENST00000900301, ENST00000900302, ENST00000900303, ENST00000900304, ENST00000900305, ENST00000900306, ENST00000900307, ENST00000972051, ENST00000972052, ENST00000972053

RefSeq mRNA: 1 — MANE Select: NM_005736 NM_005736

CCDS: CCDS7536

Canonical transcript exons

ENST00000369905 — 11 exons

ExonStartEnd
ENSE00001613806102502600102502712
ENSE00001861057102479229102480965
ENSE00003250773102482001102482175
ENSE00003466738102481837102481898
ENSE00003542714102490549102490613
ENSE00003583063102488150102488275
ENSE00003637760102489063102489138
ENSE00003643387102483011102483103
ENSE00003644632102484160102484376
ENSE00003668590102481132102481172
ENSE00003685737102485609102485733

Expression profiles

Bgee: expression breadth ubiquitous, 291 present calls, max score 98.65.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 106.0542 / max 540.4059, expressed in 1827 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
11117997.52851827
1111787.99991742
1111770.5259272

Top tissues by expression

293 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cortical plateUBERON:000534398.65gold quality
ganglionic eminenceUBERON:000402398.10gold quality
lower esophagus muscularis layerUBERON:003583397.61gold quality
lower esophagusUBERON:001347397.60gold quality
gastrocnemiusUBERON:000138897.44gold quality
prefrontal cortexUBERON:000045197.34gold quality
right frontal lobeUBERON:000281097.29gold quality
esophagogastric junction muscularis propriaUBERON:003584197.24gold quality
muscle of legUBERON:000138397.14gold quality
stromal cell of endometriumCL:000225597.03gold quality
muscle layer of sigmoid colonUBERON:003580597.02gold quality
cingulate cortexUBERON:000302796.83gold quality
anterior cingulate cortexUBERON:000983596.83gold quality
apex of heartUBERON:000209896.81gold quality
C1 segment of cervical spinal cordUBERON:000646996.79gold quality
Brodmann (1909) area 10UBERON:001354196.72gold quality
Brodmann (1909) area 9UBERON:001354096.70gold quality
popliteal arteryUBERON:000225096.60gold quality
tibial arteryUBERON:000761096.59gold quality
hindlimb stylopod muscleUBERON:000425296.58gold quality
mucosa of stomachUBERON:000119996.50gold quality
right coronary arteryUBERON:000162596.48gold quality
smooth muscle tissueUBERON:000113596.44gold quality
left coronary arteryUBERON:000162696.42gold quality
aortaUBERON:000094796.39gold quality
esophagusUBERON:000104396.39gold quality
right atrium auricular regionUBERON:000663196.30gold quality
islet of LangerhansUBERON:000000696.29gold quality
thoracic aortaUBERON:000151596.22gold quality
ascending aortaUBERON:000149696.20gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes9.83
E-MTAB-7606no744.34

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

140 targeting ACTR1A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4673100.0066.641490
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-6758-5P100.0066.211470
HSA-MIR-6856-5P100.0065.471298
HSA-MIR-3925-3P100.0069.951237
HSA-MIR-9-5P100.0072.282361
HSA-MIR-5692A100.0074.406850
HSA-MIR-150-5P99.9966.691976
HSA-MIR-6870-5P99.9968.552115
HSA-MIR-4645-5P99.9865.811284
HSA-MIR-548AN99.9770.912817
HSA-MIR-4723-5P99.9768.702034
HSA-MIR-569899.9768.492029
HSA-MIR-7111-5P99.9768.482062
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-767-5P99.9570.85993
HSA-MIR-6845-3P99.9466.881439
HSA-MIR-497-5P99.9271.832674
HSA-MIR-15A-5P99.9072.802787
HSA-MIR-15B-5P99.9072.782798
HSA-MIR-16-5P99.9072.802780
HSA-MIR-195-5P99.9072.812805
HSA-MIR-106A-5P99.9073.942683
HSA-MIR-95-5P99.8972.173973

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 78.1% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 3)

  • ARP1 interacted with two regions of the FVII 5’ flanking region, the hepatic nuclear factor 4 binding region and the nuclear hormone response region, indicating a role for ARP1 in transcriptional modulation of the FVII gene. (PMID:12871323)
  • point mutation observed by transcriptome sequencing of malignant pleural mesothelioma tumors (PMID:18303113)
  • An important role for ACTR1A in induction of pro-inflammatory cytokines.TLR2 interacts with alpha-centractin. (PMID:31221720)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerioactr1bENSDARG00000011611
mus_musculusActr1aENSMUSG00000025228
rattus_norvegicusActr1aENSRNOG00000019725
drosophila_melanogasterArp1FBGN0011745
caenorhabditis_elegansWBGENE00013168

Paralogs (26): ACTR6 (ENSG00000075089), ACTB (ENSG00000075624), ACTL6B (ENSG00000077080), ACTR5 (ENSG00000101442), ACTR3C (ENSG00000106526), ACTA2 (ENSG00000107796), ACTR8 (ENSG00000113812), ACTR1B (ENSG00000115073), ACTR3 (ENSG00000115091), ACTL8 (ENSG00000117148), ACTRT1 (ENSG00000123165), ACTR10 (ENSG00000131966), ACTR3B (ENSG00000133627), ACTL6A (ENSG00000136518), ACTR2 (ENSG00000138071), ACTA1 (ENSG00000143632), ACTL7B (ENSG00000148156), ACTC1 (ENSG00000159251), ACTG2 (ENSG00000163017), ACTBL2 (ENSG00000169067), ACTRT2 (ENSG00000169717), ACTL9 (ENSG00000181786), ACTG1 (ENSG00000184009), ACTRT3 (ENSG00000184378), ACTL7A (ENSG00000187003), ACTL10 (ENSG00000288649)

Protein

Protein identifiers

Alpha-centractinP61163 (reviewed: P61163)

Alternative names: ARP1, Actin-RPV, Centrosome-associated actin homolog

All UniProt accessions (4): P61163, A0A1B0GVS3, A0A384NQ21, R4GMT0

UniProt curated annotations — full annotation on UniProt →

Function. Part of the ACTR1A/ACTB filament around which the dynactin complex is built. The dynactin multiprotein complex activates the molecular motor dynein for ultra-processive transport along microtubules.

Subunit / interactions. Part of the ACTR1A/ACTB filament around which the dynactin complex is built. The filament contains 8 copies of ACTR1A and 1 ACTB. Interacts with dynein and adapters such as BICD2. Interacts with BCCIP (isoform 2/alpha).

Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Cell cortex.

Similarity. Belongs to the actin family. ARP1 subfamily.

RefSeq proteins (1): NP_005727* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR004000ActinFamily
IPR004001Actin_CSConserved_site
IPR020902Actin/actin-like_CSConserved_site
IPR043129ATPase_NBDHomologous_superfamily

Pfam: PF00022

UniProt features (2 total): chain 1, modified residue 1

Structure

Experimental structures (PDB)

2 structures.

PDBMethodResolution (Å)
9B85ELECTRON MICROSCOPY3.47
9B7JELECTRON MICROSCOPY3.49

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P61163-F193.000.87

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 1

Function

Pathways and Gene Ontology

Reactome pathways

33 pathways

IDPathway
R-HSA-2132295MHC class II antigen presentation
R-HSA-2565942Regulation of PLK1 Activity at G2/M Transition
R-HSA-3371497HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
R-HSA-380259Loss of Nlp from mitotic centrosomes
R-HSA-380270Recruitment of mitotic centrosome proteins and complexes
R-HSA-380284Loss of proteins required for interphase microtubule organization from the centrosome
R-HSA-380320Recruitment of NuMA to mitotic centrosomes
R-HSA-5620912Anchoring of the basal body to the plasma membrane
R-HSA-6807878COPI-mediated anterograde transport
R-HSA-6811436COPI-independent Golgi-to-ER retrograde traffic
R-HSA-8854518AURKA Activation by TPX2
R-HSA-1280218Adaptive Immune System
R-HSA-1640170Cell Cycle
R-HSA-168256Immune System
R-HSA-1852241Organelle biogenesis and maintenance
R-HSA-199977ER to Golgi Anterograde Transport
R-HSA-199991Membrane Trafficking
R-HSA-2262752Cellular responses to stress
R-HSA-380287Centrosome maturation
R-HSA-392499Metabolism of proteins
R-HSA-446203Asparagine N-linked glycosylation
R-HSA-453274Mitotic G2-G2/M phases
R-HSA-5617833Cilium Assembly
R-HSA-5653656Vesicle-mediated transport
R-HSA-597592Post-translational protein modification
R-HSA-6811442Intra-Golgi and retrograde Golgi-to-ER traffic
R-HSA-68877Mitotic Prometaphase
R-HSA-68886M Phase
R-HSA-69275G2/M Transition
R-HSA-69278Cell Cycle, Mitotic

MSigDB gene sets: 216 (showing top): GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP, TGCGCANK_UNKNOWN, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, ACTGCAG_MIR173P, GGGTGGRR_PAX4_03, GOCC_MICROTUBULE_ORGANIZING_CENTER, TTGGGAG_MIR150, NFKB_Q6, EVI1_05, GROSS_HYPOXIA_VIA_ELK3_UP, GATA1_01, GOCC_CENTROSOME

GO Biological Process (1): vesicle-mediated transport (GO:0016192)

GO Molecular Function (3): ATP binding (GO:0005524), nucleotide binding (GO:0000166), protein binding (GO:0005515)

GO Cellular Component (9): cytoplasm (GO:0005737), centrosome (GO:0005813), cytosol (GO:0005829), dynactin complex (GO:0005869), microtubule associated complex (GO:0005875), cell cortex (GO:0005938), extracellular exosome (GO:0070062), microtubule organizing center (GO:0005815), cytoskeleton (GO:0005856)

Reactome top-level categories

Rollup of top-14 pathways:

CategoryPathways
G2/M Transition3
Centrosome maturation2
Adaptive Immune System1
Cellular responses to stress1
Loss of proteins required for interphase microtubule organization from the centrosome1
Mitotic Prometaphase1
Assembly of the 9+0 primary cilium1
ER to Golgi Anterograde Transport1
Golgi-to-ER retrograde transport1
Immune System1
Membrane Trafficking1
Transport to the Golgi and subsequent modification1
Vesicle-mediated transport1
Cellular responses to stimuli1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
cytoplasm2
microtubule cytoskeleton2
transport1
cellular process1
adenyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
nucleoside phosphate binding1
heterocyclic compound binding1
binding1
intracellular anatomical structure1
centriole1
microtubule organizing center1
microtubule associated complex1
actin cytoskeleton1
protein-containing complex1
cell periphery1
extracellular vesicle1
intracellular membraneless organelle1

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

163 interactions, top by confidence:

ABTypeScore
MED4MED19psi-mi:“MI:2364”(proximity)0.900
ACTR1ADCTN2psi-mi:“MI:0914”(association)0.790
DCTN1DCTN6psi-mi:“MI:0914”(association)0.780
DCTN2DCTN6psi-mi:“MI:0914”(association)0.730
DCTN2DCTN3psi-mi:“MI:0914”(association)0.730
DYNLL1BLTP3Bpsi-mi:“MI:0914”(association)0.730
CCT2TXNDC9psi-mi:“MI:0914”(association)0.730
CFTRESYT2psi-mi:“MI:0914”(association)0.710
DCTN1DCTN3psi-mi:“MI:0914”(association)0.710
DYNC1I2DYNC1LI2psi-mi:“MI:0914”(association)0.680
MIS18ADCTN6psi-mi:“MI:0914”(association)0.640
DYNLL2BLTP3Bpsi-mi:“MI:0914”(association)0.640
CAPZBCNOT1psi-mi:“MI:0914”(association)0.640
CAPZA2CNOT1psi-mi:“MI:0914”(association)0.640
DCTN5DCTN6psi-mi:“MI:0914”(association)0.640
PDCL3PEX7psi-mi:“MI:0914”(association)0.640
CCT3TXNDC9psi-mi:“MI:0914”(association)0.640

BioGRID (393): ACTR1A (Affinity Capture-MS), ACTR1A (Affinity Capture-RNA), ACTR1A (Affinity Capture-RNA), ACTR1A (Affinity Capture-MS), ACTR1A (Affinity Capture-MS), ACTR1A (Affinity Capture-MS), ACTR1A (Co-fractionation), ACTR1A (Co-fractionation), ACTR1A (Co-fractionation), ACTR1A (Co-fractionation), ACTR1A (Co-fractionation), ACTR1A (Co-fractionation), ACTR1A (Co-fractionation), ACTR1A (Co-fractionation), ACTR1A (Co-fractionation)

ESM2 similar proteins: A2VD93, A2WNB0, A2XMK6, A3ANB5, A4FUX8, A4IFE3, O00937, O94241, O94805, O96019, O96621, P02583, P12715, P20360, P32381, P42023, P42025, P45888, P45889, P45890, P47117, P51775, P53468, P53469, P53489, P53499, P55805, P61162, P61163, P61164, P85515, P86173, Q09443, Q09849, Q2YDD0, Q4R333, Q4R6J2, Q4R6J9, Q54I79, Q5NBI2

Diamond homologs: A2BDB0, A2XLF2, A2XNS1, A3C6D7, A4IFE3, F2Z5G5, O17320, O18840, O65314, O81221, P02578, P04829, P0C539, P0CJ46, P0CJ47, P0DM41, P0DM42, P10981, P10984, P10986, P10990, P17304, P30162, P30163, P30167, P30171, P38673, P42023, P42025, P45885, P45886, P45889, P48465, P48975, P53455, P53456, P53457, P53458, P53470, P53471

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 157 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
COPI-independent Golgi-to-ER retrograde traffic1733.3×2e-19
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand1527.4×1e-15
Aggrephagy1023.4×5e-10
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding623.1×6e-06
Formation of tubulin folding intermediates by CCT/TriC519.9×1e-04
RHO GTPases activate IQGAPs619.6×2e-05
Prefoldin mediated transfer of substrate to CCT/TriC518.6×1e-04
Loss of Nlp from mitotic centrosomes1218.0×2e-10

GO biological processes:

GO termPartnersFoldFDR
positive regulation of microtubule polymerization630.9×2e-05
mitotic spindle organization612.4×2e-03
microtubule-based movement511.3×8e-03
microtubule cytoskeleton organization1110.2×1e-05

Disease & clinical

Clinical variants and AI predictions

ClinVar

39 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic2
Likely pathogenic0
Uncertain significance18
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (2)

Variant IDHGVSClassification
3342255Single allelePathogenic
58780GRCh38/hg38 10q24.32-24.33(chr10:102243341-103929730)x1Pathogenic

SpliceAI

3418 predictions. Top by Δscore:

VariantEffectΔscore
10:102469159:GT:Gdonor_gain1.0000
10:102469992:GACA:Gacceptor_gain1.0000
10:102470094:GCTC:Gdonor_gain1.0000
10:102470135:G:GTdonor_gain1.0000
10:102470972:G:GTdonor_gain1.0000
10:102471271:A:AGacceptor_gain1.0000
10:102471272:G:GGacceptor_gain1.0000
10:102472946:GTTGG:Gdonor_gain1.0000
10:102472947:TTGGG:Tdonor_loss1.0000
10:102472948:TGGGT:Tdonor_loss1.0000
10:102472949:GG:Gdonor_gain1.0000
10:102472949:GGGT:Gdonor_loss1.0000
10:102472950:GG:Gdonor_gain1.0000
10:102472950:GGT:Gdonor_loss1.0000
10:102472952:TGAG:Tdonor_loss1.0000
10:102472953:GAGT:Gdonor_loss1.0000
10:102473565:CCCA:Cacceptor_loss1.0000
10:102473566:CCAGG:Cacceptor_loss1.0000
10:102473567:CAGG:Cacceptor_loss1.0000
10:102473568:A:AGacceptor_gain1.0000
10:102473568:A:Cacceptor_loss1.0000
10:102473568:AG:Aacceptor_gain1.0000
10:102473569:G:GGacceptor_gain1.0000
10:102473569:GG:Gacceptor_gain1.0000
10:102473569:GGC:Gacceptor_gain1.0000
10:102473569:GGCCT:Gacceptor_gain1.0000
10:102473739:CAGG:Cdonor_loss1.0000
10:102473740:AGGTA:Adonor_loss1.0000
10:102473741:GGTA:Gdonor_loss1.0000
10:102473742:G:Cdonor_loss1.0000

AlphaMissense

2454 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
10:102480951:G:TA348D1.000
10:102480963:C:TG344D1.000
10:102480964:C:GG344R1.000
10:102481132:C:AG343V1.000
10:102481132:C:TG343E1.000
10:102481133:C:AG343W1.000
10:102481133:C:GG343R1.000
10:102481133:C:TG343R1.000
10:102481139:A:GW341R1.000
10:102481139:A:TW341R1.000
10:102482021:C:TG302E1.000
10:102484335:C:TG161E1.000
10:102484336:C:AG161W1.000
10:102484353:C:TG155E1.000
10:102484354:C:AG155W1.000
10:102484354:C:GG155R1.000
10:102484354:C:TG155R1.000
10:102485723:A:GL109P1.000
10:102488197:A:GW90R1.000
10:102488197:A:TW90R1.000
10:102490592:C:GG24R1.000
10:102490612:C:TG17E1.000
10:102502613:A:TV12D1.000
10:102480925:A:GW357R0.999
10:102480925:A:TW357R0.999
10:102480935:A:CF353L0.999
10:102480935:A:TF353L0.999
10:102480937:A:GF353L0.999
10:102480945:A:GL350P0.999
10:102480952:C:GA348P0.999

dbSNP variants (sampled 300 via entrez): RS1000011576 (10:102479760 A>C,G), RS1000108508 (10:102501291 A>G), RS1000179250 (10:102497795 AGAGAAAGGATAGGGTT>A), RS1000202518 (10:102483407 T>A,C), RS1000207326 (10:102491454 A>G), RS1000353249 (10:102494120 G>A), RS1000362988 (10:102479418 G>A,C,T), RS1000411697 (10:102503462 A>G), RS1000544013 (10:102496396 G>A), RS1000804231 (10:102485017 T>C), RS1000836347 (10:102482852 A>C), RS1000903610 (10:102492552 CTAAG>C), RS1000955573 (10:102492113 C>T), RS1001172987 (10:102489244 A>G), RS1001188825 (10:102480448 G>T)

Disease associations

OMIM: gene MIM:605143 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

13 associations (top):

StudyTraitp-value
GCST001942_1Prostate cancer5.000000e-10
GCST004521_172Autism spectrum disorder or schizophrenia4.000000e-14
GCST004521_53Autism spectrum disorder or schizophrenia9.000000e-10
GCST005038_102Allergic disease (asthma, hay fever or eczema)2.000000e-08
GCST005956_50Waist-to-hip ratio adjusted for BMI8.000000e-06
GCST005958_15Waist-to-hip ratio adjusted for BMI (age >50)4.000000e-06
GCST005962_36Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)6.000000e-07
GCST006409_9Allergic rhinitis5.000000e-18
GCST007387_8Insomnia symptoms (never/rarely vs. sometimes/usually)5.000000e-08
GCST007388_47Insomnia symptoms (never/rarely vs. usually)4.000000e-11
GCST010002_298Refractive error3.000000e-22
GCST010703_271Brain morphology (MOSTest)5.000000e-13
GCST012227_616Hip circumference adjusted for BMI4.000000e-11

EFO canonical traits (6, from GWAS)

EFO IDTrait name
EFO:0007788BMI-adjusted waist-hip ratio
EFO:0008007age at assessment
EFO:0008343sex interaction measurement
EFO:0007876insomnia measurement
EFO:0004346neuroimaging measurement
EFO:0008039BMI-adjusted hip circumference

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

36 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases expression, increases expression2
Tobacco Smoke Pollutionaffects expression, increases expression2
bisphenol Faffects cotreatment, increases expression1
triphenyl phosphateaffects expression1
sodium arseniteincreases expression1
cobaltous chloridedecreases expression1
diallyl trisulfideincreases expression1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic aciddecreases expression1
tanespimycinaffects cotreatment, decreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression1
VER 155008affects cotreatment, decreases expression1
LDN 193189increases expression, affects cotreatment1
Atrazineincreases expression1
Benztropineaffects cotreatment, increases expression1
Cisplatinincreases expression1
Cuprizoneaffects cotreatment, increases expression1
Dexamethasoneaffects cotreatment, increases expression1
Doxorubicindecreases expression1
Furaldehydeaffects cotreatment, affects localization, increases expression1
Hydrogen Peroxideincreases expression1
Indomethacinincreases expression, affects cotreatment1
Ivermectindecreases expression1
Methotrexateaffects response to substance1
Quercetinincreases expression1
Seleniumincreases expression1
Smokedecreases expression1
Sodium Chlorideaffects cotreatment, affects localization, increases expression1
T-2 Toxinincreases expression1
Dronabinoldecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): allergic rhinitis